OCI NV (OCI.AS) Stock Fundamental Analysis
AMS:OCI - Euronext Amsterdam - NL0010558797 - Common Stock - Currency: EUR
OCI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 69 industry peers in the Chemicals industry. OCI has a bad profitability rating. Also its financial health evaluation is rather negative. OCI does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year OCI has reported negative net income.
OCI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: OCI reported negative net income in multiple years.
Each year in the past 5 years OCI had a positive operating cash flow.
1.2 Ratios
OCI has a worse Return On Assets (-5.28%) than 72.46% of its industry peers.
OCI's Return On Equity of -51.53% is on the low side compared to the rest of the industry. OCI is outperformed by 85.51% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.28% | ||
| ROE | -51.53% | ||
| ROIC | N/A |
ROA(3y)41.1%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Profit Margin of OCI has grown nicely.
Looking at the Gross Margin, with a value of 2.23%, OCI is doing worse than 88.41% of the companies in the same industry.
In the last couple of years the Gross Margin of OCI has declined.
OCI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 2.23% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
2. Health
2.1 Basic Checks
OCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OCI has about the same amount of shares outstanding.
Compared to 5 years ago, OCI has more shares outstanding
OCI has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.20, we must say that OCI is in the distress zone and has some risk of bankruptcy.
OCI has a worse Altman-Z score (0.20) than 85.51% of its industry peers.
The Debt to FCF ratio of OCI is 44.52, which is on the high side as it means it would take OCI, 44.52 years of fcf income to pay off all of its debts.
OCI has a Debt to FCF ratio (44.52) which is in line with its industry peers.
OCI has a Debt/Equity ratio of 2.03. This is a high value indicating a heavy dependency on external financing.
OCI's Debt to Equity ratio of 2.03 is on the low side compared to the rest of the industry. OCI is outperformed by 89.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.03 | ||
| Debt/FCF | 44.53 | ||
| Altman-Z | 0.2 |
ROIC/WACCN/A
WACC6.26%
2.3 Liquidity
A Current Ratio of 1.39 indicates that OCI should not have too much problems paying its short term obligations.
OCI has a Current ratio of 1.39. This is in the lower half of the industry: OCI underperforms 69.57% of its industry peers.
A Quick Ratio of 1.37 indicates that OCI should not have too much problems paying its short term obligations.
OCI has a Quick ratio of 1.37. This is in the better half of the industry: OCI outperforms 71.01% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.39 | ||
| Quick Ratio | 1.37 |
3. Growth
3.1 Past
OCI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -123.19%.
Measured over the past years, OCI shows a very strong growth in Earnings Per Share. The EPS has been growing by 105.88% on average per year.
OCI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -58.51%.
Measured over the past years, OCI shows a very negative growth in Revenue. The Revenue has been decreasing by -20.30% on average per year.
EPS 1Y (TTM)-123.19%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%164.52%
Revenue 1Y (TTM)-58.51%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-11.72%
3.2 Future
Based on estimates for the next years, OCI will show a very strong growth in Earnings Per Share. The EPS will grow by 71.49% on average per year.
The Revenue is expected to decrease by -14.70% on average over the next years. This is quite bad
EPS Next Y770.92%
EPS Next 2Y251.29%
EPS Next 3Y133.31%
EPS Next 5Y71.49%
Revenue Next Year-27.81%
Revenue Next 2Y-14.07%
Revenue Next 3Y-23.72%
Revenue Next 5Y-14.7%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for OCI. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 20.10, which indicates a rather expensive current valuation of OCI.
OCI's Price/Forward Earnings ratio is in line with the industry average.
OCI's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.19.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 20.1 |
4.2 Price Multiples
The rest of the industry has a similar Price/Free Cash Flow ratio as OCI.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.97 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
OCI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
OCI's earnings are expected to grow with 133.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y251.29%
EPS Next 3Y133.31%
5. Dividend
5.1 Amount
No dividends for OCI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMS:OCI (6/19/2025, 5:29:47 PM)
7.75
-0.01 (-0.13%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners32.13%
Inst Owner ChangeN/A
Ins Owners8.71%
Ins Owner ChangeN/A
Market Cap1.64B
Analysts75.38
Price Target11.97 (54.45%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend13.24
Dividend Growth(5Y)N/A
DP-36.26%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)486.8%
Min EPS beat(2)232.01%
Max EPS beat(2)741.58%
EPS beat(4)2
Avg EPS beat(4)85.49%
Min EPS beat(4)-492.57%
Max EPS beat(4)741.58%
EPS beat(8)3
Avg EPS beat(8)31.49%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)37.56%
Min Revenue beat(2)20.15%
Max Revenue beat(2)54.98%
Revenue beat(4)2
Avg Revenue beat(4)8.41%
Min Revenue beat(4)-23.05%
Max Revenue beat(4)54.98%
Revenue beat(8)5
Avg Revenue beat(8)21.58%
Revenue beat(12)9
Avg Revenue beat(12)32.19%
Revenue beat(16)12
Avg Revenue beat(16)36.43%
PT rev (1m)-14.69%
PT rev (3m)-26.63%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-24.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 20.1 | ||
| P/S | 0.41 | ||
| P/FCF | 34.97 | ||
| P/OCF | 3.41 | ||
| P/B | 2.05 | ||
| P/tB | 2.17 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.42
EYN/A
EPS(NY)0.39
Fwd EY4.97%
FCF(TTM)0.22
FCFY2.86%
OCF(TTM)2.27
OCFY29.34%
SpS18.72
BVpS3.78
TBVpS3.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.28% | ||
| ROE | -51.53% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 2.23% | ||
| FCFM | 1.18% |
ROA(3y)41.1%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
F-Score3
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.03 | ||
| Debt/FCF | 44.53 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | -4159.17% | ||
| Cap/Sales | 10.96% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.39 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | 0.2 |
F-Score3
WACC6.26%
ROIC/WACCN/A
Cap/Depr(3y)137.7%
Cap/Depr(5y)97.09%
Cap/Sales(3y)24.99%
Cap/Sales(5y)17.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-123.19%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%164.52%
EPS Next Y770.92%
EPS Next 2Y251.29%
EPS Next 3Y133.31%
EPS Next 5Y71.49%
Revenue 1Y (TTM)-58.51%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-11.72%
Revenue Next Year-27.81%
Revenue Next 2Y-14.07%
Revenue Next 3Y-23.72%
Revenue Next 5Y-14.7%
EBIT growth 1Y-118.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year309.47%
EBIT Next 3Y-17.67%
EBIT Next 5Y-4.61%
FCF growth 1Y-95.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.4%
OCF growth 3Y-68.9%
OCF growth 5Y-27.39%